2019 Cannabis Business Award's Publication of the Year |
WEDNESDAY, SEPTEMBER 11, 2024 |
FMCPG HAS BEEN SERVING AND REPRESENTING THE CANNABIS PHYSICIAN COMMUNITY
SINCE 2020 |
THE
"FLORIDA MEDICAL CANNABIS PHYSICIAN GROUP"
(FMCPG) FOR ALL
"MEDICAL MARIJUANA DOCTORS"
AND "MMTC DIRECTORS ONLY " DISCUSSION WILL INCLUDE: REVIEW OF THE OMMU AND CHANGES TO THE DOCTOR'S PATIENT INPUT PORTAL ON THE OMMU WEBSITE.
DOCTORS WITHIN OUR GROUP WILL DISCUSS HOW THEY HAVE BEEN WORKING AROUND SOME OF THE CHANGES
LEGISLATIVE AGENDA FOR 2024 -2025
REF'S ISSUES AND SOLUTIONS
CLICK HERE TO REGISTER FOR THE SEPT 11, 2024 MEETING |
MEDICAL CANNABIS PHYSICIAN PROMOTION PACKAGE BY
CANNABIS NEWS FLORIDA ARTICLE: Physician will contribute an article of 350 words**. This article will appear in the Cannabis News Florida e-newsletter for one month (4 weeks). E-MAIL BLAST: Cannabis News Florida will send out one e-mail blast promoting the Physician to the other physicians in three zip code areas or one city to be determined by the Physician. The Physician will supply the information for the email blast. The Article above can be used in the e-mail blast. The cost of this program is ONLY $500.
**Cannabis News Florida will assign a writer for a telephone interview with the Physician and create the article to be published. Physician shall have the right to review and approve the article before publication for an additional cost of $100.
IF YOU ARE INTERESTED, PLEASE EMAIL ME AT CHARLES@CANNABISNEWSFLORIDA.COM OR CALL MY CELL AT 954-605-4785 |
NEWS FROM THE PAST WEEK RELATING TO THE BUSINESS OF
MMTC'S IN FLORIDA Click on Company Logo to be Transferred to Web Site |
Trulieve Opens Relocated Dispensary in Tucson, Arizona
New Menlo Park location to celebrate grand opening Friday, September 13th
TALLAHASSEE, Fla., Sept. 4, 2024 — Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the United States, today announced the relocation of a dispensary in Tucson, Arizona.
The new Menlo Park location at 1010 S Freeway #130 will host a grand opening celebration starting at 8 a.m. Friday, September 13, with partner giveaways, DJs, special discounts and more.
“We are always looking for ways to improve upon our elite customer experience,” said Trulieve’s Chief Executive Officer Kim Rivers. “This new location features a more spacious showroom for serving our patrons in Menlo Park and South Tucson.”
READ MORE |
Trulieve to Open Medical Cannabis Dispensary in Clearwater, Florida
New Pinellas County location will host grand opening celebration Friday, September 13th
TALLAHASSEE, Fla., Sept. 6, 2024 — Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the U.S., announced the opening of a new medical cannabis dispensary in Clearwater, Florida on Saturday, September 7.
A grand opening celebration will be held Friday, September 13, beginning at 9 a.m., featuring music, specials, discounts, and opportunities to register for upcoming patient education sessions as well as learn about #YesOn3 and the ballot initiative to legalize adult cannabis use in Florida.
“We work to provide value, deliver quality, and enhance lives through cannabis in every community we serve,” said Trulieve’s Chief Executive Officer Kim Rivers. “This new dispensary near the intersection of US-19 and Roosevelt Boulevard offers another convenient location to patients and caregivers in central Pinellas County.”
READ MORE |
The Cannabist Company Introduces Popular Brand Seed & Strain to Pennsylvania
Launch Marks 11th Market For Brand
NEW YORK–Sep. 10, 2024– The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQX: CBSTF) (FSE: 3LP) (“The Cannabist Company” or the “Company”), one of the most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., announced today the launch of its brand Seed & Strain into the Pennsylvania market.
Seed & Strain debuts in Pennsylvania with 1.0-gram vape cartridges and whole flower and is available at the Columbia Care locations in Allentown, Scranton and Wilkes-Barre, and across the Company’s wholesale channels. Additional products will be available in the coming weeks pending regulatory approval.
Seed & Strain is a true reflection of the passion The Cannabist Company has for the plant. With the introduction of these products, Seed & Strain is now available in 11 markets across the country. From whole flower, pre-rolls, vapes, and concentrates to tinctures, topicals and more, each offering is a testament to the company’s craft and care. New offerings were made available over the last year including the introduction of popular items like disposable vapes in New Jersey, Massachusetts and Virginia. Products will continue to roll out over the coming months, pending regulatory review.
READ MORE |
AYR Wellness Secures Conditional Approval to Establish Vertical Medical Cannabis Operations in Virginia
MIAMI, Sept. 05, 2024 — AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, today announced that it was awarded conditional approval to serve as a pharmaceutical processor by the Virginia Cannabis Control Authority (“CCA”) for Virginia’s Health Service Area 1 (“HSA 1”). HSA 1 encompasses various cities and counties in Virginia, including Charlottesville, Fredericksburg, Spotsylvania, and Stafford.
“We’re proud to have earned the opportunity to serve patients in Virginia, particularly in a region of ~1.5 million people that has lacked access to medical cannabis for some time,” said David Goubert, President & CEO of AYR. “This is an exciting moment for AYR, reflective of our continued efforts towards building our business to generate sustainable forward-looking growth.”
READ MORE |
This Week's Viridian Regional Tracker dives into YTD capital raise activity for cannabis companies by State -- the type of capital flow trend analysis we've been tracking since January 2015.
There's been a consistent rotation of capital in and out of these regions over time. Our data provides insight as to how to interpret and capitalize on these trends.
View This Week's Viridian Regional Deal Tracker For a Deeper Dive Into M&A and Capital Raise Transactions by U.S. State
Wondering if Now is the Time to Sell Your Profitable State Licensed Company? Contact Us We'll Give You the Facts About How Buyers Are Paying in the Current Market
READ MORE |
NATIONAL AND INTERNATIONAL NEWS |
Tilray Medical Supports Scientific Study on Fibromyalgia With Positive Outcomes: Effectiveness of Cannabinoids Treatment in Pain Management and Other Fibromyalgia-Associated Symptoms
LISBON, Portugal, Sept. 09, 2024 — Tilray Medical, a division of Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, today announced a new scientific publication supported by Tilray Medical titled, Treatment in Pain Management and Other Fibromyalgia-Associated Symptoms: A Case Series (TOMAS). The study examines the real-world impact of cannabinoid treatments on patients with fibromyalgia (FM) under the guidance of healthcare providers.
The TOMAS study, consisting of patients with an average age of 52 years, examined the effects of Tilray Dried Flower THC18 on chronic pain and other FM-associated symptoms. The study sheds light on the impact of cannabinoids on health outcomes, with a particular focus on pain, sleep, and quality of life.
READ MORE |
Rubicon Organics Announces Board Appointment and DSU Grant
VANCOUVER, British Columbia, Sept. 09, 2024 — Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis, is pleased to announce that Jesse McConnell has been appointed to the Company’s Board of Directors (“Board”) after receipt of security clearance from Health Canada. Mr. McConnell was elected to the Board by the shareholders at the Annual General Meeting on July 31, 2024, but his appointment to the Board was subject to being granted security clearance by Health Canada.
READ MORE |
High Kings Launches Pairing of Ultra Premium Cigars & Cannagars in U.S. Premium Import Cigar Market
SAN CLEMENTE, Calif., Sept. 03, 2024 — High Kings of Tara, LLC (HKOT), a Calif.-based producer of ultra-premium cigars, announced today that it will co-market its Ultra-Premium Tobacco Cigars with its Ultra-Premium Cannagars in two multi-billion-dollar markets – imported tobacco cigars and the U.S.-legal CBD flower smokables market – serving cigar connoisseurs seeking a unique, high-quality, relaxing smoking experience.
HKOT is one of the first brands to market BOTH tobacco cigars and cannagars together as a Pairing of products available to the general public of legal age.
“Cigars and Cannagars are the perfect pairing companions because Cannagars open up the cigar world to millions of connoisseurs who wish to enjoy a more sophisticated smoking experience,” said HKOT CEO Ned Madden. “Through the Cannagar, a much wider audience can now join into the cigar culture enjoying its traditions, practices and most importantly the lifestyle. The cigar industry is deeply rooted in history, luxury, and shared camaraderie, making the Cannagar a perfect fit.”
READ MORE | HYTN Partners with the UK’s 4C Labs, Validates GMP Certification
VANCOUVER, British Columbia, Sept. 10, 2024 — HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or “the Company”), a pharmaceutical company specializing in the development, formulation, and manufacturing of psychoactive and psychotropic compounds, including cannabinoids and psilocybin, is proud to announce the establishment of international manufacturing and pricing agreements (the Agreements) with 4C LABS, a leading importer and distributor of cannabis-based pharmaceuticals in the United Kingdom. These agreements aim to enable the production of cannabis products in bulk and final packaged forms for distribution in the UK and other global markets. Through this partnership HYTN will act as the manufacturer, packager and exporter of pharmaceutical quality cannabis goods that 4C LABS may purchase and subsequently import and distribute into the UK market.
READ MORE |
MariMed’s Bubby’s Baked Introduces New, Limited-Edition Pumpkin Bread Bites This Autumn
Bubby’s Baked Pumpkin Bread Bites Feature Real Pumpkin and a Delicious Blend of Cinnamon, Ginger, Allspice, and Nutmeg for a Warm Hug in Mini Muffin Form
NORWOOD, Mass., Sept. 10, 2024 — Bubby’s Baked, the small-batch and made-from-scratch soft and delicious cannabis bites, has officially launched a new limited-edition batch of mini muffins for autumn: Pumpkin Bread Bites. Bubby’s Baked is one of the award-winning brands developed and distributed by leading multi-state cannabis operator, MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD). All Bubby’s Baked mini muffins are baked fresh with real, simple ingredients and no artificial ingredients or preservatives.
Each Pumpkin Bread Bite features the staple fall flavor, made with real pumpkin as well as a warm spice blend of cinnamon, ginger, allspice, and nutmeg. Infused with a precise, full-spectrum dose of high-quality cannabis, they are now available for both adult-use and medical cannabis customers at MariMed dispensaries and other select cannabis retailers in Massachusetts. They will be available in Maryland, Illinois, and Delaware soon.
READ MORE | Optimi Health & ATMA Receive No Objection Letter from Health Canada for Phase 2 Clinical Trial
VANCOUVER, BC – August 28, 2024 – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (“Optimi” or the “Company“), a GMP-compliant, Health Canada-licensed manufacturer of psychedelics pharmaceuticals specializing in botanical psilocybin and MDMA, is pleased to announce the receipt of a No Objection Letter (NOL) from Health Canada. This authorization permits the use of the Company’s GMP natural psilocybin extract capsules in a Phase 2 clinical trial, conducted in collaboration with ATMA Journey Centers LTD. (“ATMA“).
Advancing Clinical Validation in Canada
The approval to initiate this Phase 2 clinical trial represents a pivotal moment in the clinical development of Optimi’s GMP natural psilocybin extract capsules. Building on its established status as a treatment option for patients with treatment-resistant depression (TRD) in Australia, this trial will provide a rigorous evaluation of the capsules in 200 participants within a controlled clinical environment in Canada. The study is scheduled to commence in the coming months, and is expected to yield valuable insights that will contribute to the broader understanding of psilocybin as a potential therapeutic option within the Canadian healthcare system.
READ MORE |
Tilray Brands Completes Acquisition of Craft Beer Brands and Breweries from Molson Coors Beverage Company Sep 3, 2024
NEW YORK, Sept. 03, 2024 — Tilray Brands, Inc. (“Tilray”, “our”, “we” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company, has successfully completed the previously announced acquisition of craft breweries Hop Valley Brewing Company, Terrapin Beer Co., and Revolver Brewing, from Molson Coors Beverage Company (“Molson Coors”) (NYSE: TAP).
Irwin D. Simon, Chairman and Chief Executive Officer of Tilray Brands, said, “Tilray Brands is crafting a new future for brands in the craft beer industry. We are proud to welcome these exceptional brands and the talented teams behind them to Tilray. With our proven track record of creating brand growth, we are confident in our ability to drive revenue, generate cost synergies, and expand distribution, further strengthening these brands and solidifying Tilray’s position as a leader in the craft beverage industry. This strategic acquisition creates additional growth opportunities for our global beverage business, which reinforces our commitment to enhancing shareholder value. At Tilray Brands, we are constantly pushing the boundaries to bring new and better experiences to our consumers. Our plan is to drive growth and maximize the potential of these brands to their fullest capacity, while maintaining our dedication to delivering high-quality products and meeting the evolving needs of our consumers.”
READ MORE |
BELOW ARE THE LINKS TO THE DIRECTORY OF FLORIDA CANNABIS DOCTORS AND
DISPENSARIES IN THE STATE OF FLORIDA |
QUALIFIED PATIENTS
OVER 886,000
AND 674 DISPENSING LOCATIONS |
LATEST OMMU REPORTS FROM OFFICE OF MEDICAL MARIJUANA USE IN THE STATE OF FLORIDA Highlights from
SEPTEMBER 6, 2024 Report BY THE NUMBERS
Qualified Patients: (Active ID Card) SEPT 06 2024- 886,232 AUG 30 2024- 885,373
AUG 23 2024- 885,409
AUG 16 2024- 885,040
AUG 09 2024- 884,982
AUG 02 2024- 884,941
Pattients Last Week: 859
Qualified Ordering Physicians: 2,365
New Doctors Last Week: 10 Reporting Period: AUGUST 30 TO SEPTEMBER 5, 2024
Amount of Medical Marijuana Dispensed - (mgs THC) 361,478,216
Amount of Low-THC Cannabis Dispensed - (mgs CBD) 3,595,143
Amount of Marijuana in a From for Smoking (oz) 126,769.001
Approved Dispensing Locations: 674
Added Last Week: 1 TRULIEVE - CLEARWATER |
UPCOMING MEETING AND CONFERENCES |
Don’t miss this important one-day event! September 25th – FSU Turnbull Center – Tallahassee
The most comprehensive information related to Florida’s changing marijuana marketplace. Florida could soon be the biggest marijuana market in the country! Register now to meet the people and hear the voices that will shape the future of Florida’s marijuana industry. For more information visit our website or contact MMBAFL@tmcshows.com. (850) 385-3595.
READ MORE |
CANNABIS NEWS FLORIDA READERS CAN RECEIVE A
20% REGISTRATION DISCOUNT BY USING THIS CODE WHEN YOU REGISTER CNF20 |
2024 Florida Cannabis Festival November 2nd and 3rd |
ADVERTISEMENT OPPORTUNITIES
If your goal is to get your business in front of the right people in the cannabis industry or you want to be an integral part of this new and exciting business opportunity, then you need to join with Cannabis News Florida as we help to establish cannabis as a major part of the economy in Florida. Cannabis News Florida is an online publication focusing on both local and national news from leading authorities about the medical and business developments in the medical cannabis industry covering the entire state of Florida.
Join the Cannabis News Florida force online and in print. We offer several marketing options to fit all budgets:
· MMTC PROMOS LISTED IN EACH E-NEWSLETTER
• Directory Listing
• Banner Ads
• Ad Space in the Newspaper
• Feature Articles
• Weekly Newsletters
For further information or to make your ad reservation, please call:561-368-6950 / 954-605-4785 cell charles@cannabisnewsflorida.com
|
|
|